Jazz Pharmaceuticals Operating Expenses 2010-2024 | JAZZ

Jazz Pharmaceuticals operating expenses for the twelve months ending September 30, 2024 were $3.344B, a 7.14% decline year-over-year.

  • Jazz Pharmaceuticals annual operating expenses for 2023 were $3.256B, a 12.6% decline from 2022.
  • Jazz Pharmaceuticals annual operating expenses for 2022 were $3.725B, a 27.39% increase from 2021.
  • Jazz Pharmaceuticals annual operating expenses for 2021 were $2.924B, a 47.27% increase from 2020.

Jazz Pharmaceuticals Operating Expenses 2010-2024 | JAZZ

  • Jazz Pharmaceuticals annual operating expenses for 2023 were $3.256B, a 12.6% decline from 2022.
  • Jazz Pharmaceuticals annual operating expenses for 2022 were $3.725B, a 27.39% increase from 2021.
  • Jazz Pharmaceuticals annual operating expenses for 2021 were $2.924B, a 47.27% increase from 2020.